• BAPTA as a Causal Probe of Calcium Signaling

  2026-09-20

  BAPTA is a high-affinity calcium chelator that helps researchers test whether calcium flux is causally involved in apoptosis and cell signaling. This article translates recent IP3R/Ca2+/STAT3 evidence into practical assay-design decisions, controls, and interpretation strategies.

• TSA Mapping of BRAF-Driven Pain Signaling

  2026-09-19

  A translational framework for using tyramide signal amplification to visualize BRAF-associated synaptic remodeling and low-abundance molecular signals in neuropathic pain research.

• Dimetridazole Revives Cefotaxime Against MDR E. coli

  2026-09-18

  A 2025 Scientific Reports study shows that Dimetridazole can potentiate cefotaxime against a multidrug-resistant E. coli strain by compromising membrane integrity, permeability, and fatty-acid biosynthesis. The work combines checkerboard synergy testing, microscopy, lipid analysis, gene-expression measurements, and Galleria mellonella infection model research to connect phenotypic rescue with a membrane-centered mechanism.

• SpCas9 mRNA (ARCA, 5mCTP, ψUTP) for Reliable Editing

  2026-09-18

  Learn how SpCas9 mRNA (ARCA, 5mCTP, ψUTP), SKU R1006, can support more interpretable CRISPR-Cas9 experiments linked to cell viability, proliferation, and cytotoxicity assays. This scenario-based guide covers formulation, delivery controls, protocol optimization, data interpretation, and practical product selection.

• Electroporation for CRISPR Editing in Mouse Zygotes

  2026-09-17

  Hashimoto and Takemoto showed that electroporation can deliver Cas9 mRNA and guide RNA into mouse zygotes without removing the zona pellucida, providing a scalable alternative to embryo microinjection. Their optimized workflow supported both CRISPR/Cas9-mediated gene disruption and ssODN-mediated knock-in, while emphasizing the need to balance RNA uptake with embryo survival.

• PP2A, Autophagy, and Candida Biofilm Resistance

  2026-09-17

  The reference study identifies PP2A, encoded by PPH21, as an upstream regulator of autophagy-linked biofilm formation and antifungal resistance in Candida albicans. Its genetic, pharmacologic, cellular, and mouse oral-infection experiments support a PPH21–Atg13–Atg1 pathway that may help explain why autophagy activation reduces treatment efficacy in biofilm-associated infection.

• Ibrexafungerp Activity Against Resistant Candida auris

  2026-09-16

  The reference study combines susceptibility testing of 54 Candida auris isolates with a delayed-treatment neutropenic mouse model to assess ibrexafungerp, also known as MK 3118. Its consistent in vitro activity and improved survival and kidney fungal-burden outcomes against a fluconazole-resistant isolate support further investigation, while the limited in vivo strain set and animal-model design constrain direct clinical interpretation.

• SpCas9 mRNA for Efficient Genome Editing

  2026-09-16

  SpCas9 mRNA enables transient, DNA-free Cas9 expression for site-specific editing in embryos and other eukaryotic research systems. Its ARCA cap, poly(A) tail, and 5mCTP/ψUTP chemistry support a practical workflow focused on RNA integrity, efficient delivery, and controlled exposure.

• Dimetridazole as a Context-Dependent Antivirulence Tool

  2026-09-15

  Dimetridazole research is moving beyond simple growth inhibition toward context-dependent control of quorum sensing, virulence, and combination antibiotic performance. This article explains how to design assays that distinguish direct antimicrobial effects from antivirulence activity and translate findings into infection model research.

• RepSox and the Next Frontier of hiPSC Platelet Science

  2026-09-15

  A mechanistic and translational perspective on how RepSox, a potent and selective ALK5 inhibitor, could help researchers interrogate TGF-β signaling during induced pluripotent stem cell reprogramming and platelet differentiation. The article connects recent hiPSC platelet-production advances with practical assay design, competitive strategy, and the limitations that must be resolved before RepSox can be positioned within a manufacturing workflow.

• Leonurine, STING, and Doxorubicin Cardiotoxicity

  2026-09-14

  This Advanced Science study identifies cardiac vascular endothelial cells as early sensors and amplifiers of doxorubicin cardiotoxicity, linking endothelial cGAS–STING activation to NLRP3-mediated pyroptosis, pathogenic extracellular vesicles, and cardiomyocyte mitochondrial injury. It further presents leonurine as a direct STING inhibitor that binds TYR261, suggesting an endothelial-centered therapeutic strategy rather than a cardiomyocyte-only approach.

• Lysis Buffer: From Mouse DNA to Model Quality

  2026-09-14

  Explore how lysis buffer supports genomic DNA release from mouse tail samples and why pre-analytical control matters for mouse genotyping. This evidence-led guide connects rapid tissue processing with the assay-design lessons of a multi-omics colorectal cancer study.

• Oseltamivir acid: Research Workflows & Troubleshooting

  2026-09-13

  Oseltamivir acid supports orthogonal influenza neuraminidase, cell-based replication, resistance, and oncology assays without requiring prodrug activation in the test system. This workflow-focused guide connects practical compound handling with humanized-mouse pharmacokinetic principles while separating established evidence from optimization starting points.

• Idoxuridine: Viral DNA Synthesis Workflow

  2026-09-12

  Build a reproducible viral replication assay around Idoxuridine, from DMSO stock preparation to orthogonal DNA and viability readouts. The workflow emphasizes mechanism-aligned controls, practical troubleshooting, and a careful translation of human-neuron assay principles without overstating antiviral evidence.

• ddATP Workflows for DNA Synthesis Termination

  2026-09-11

  ddATP gives researchers a tunable way to terminate DNA synthesis at adenine-directed incorporation sites, supporting sequencing, polymerase profiling, and DNA damage studies. This guide connects practical assay design with evidence from a mouse-oocyte break-induced replication model while distinguishing validated findings from workflow starting points.

8324 records 1/555 page Next 12345 下5页 Last page